Back to search

Article

Leveraging AI for facioscapulohumeral muscular dystrophy prediction and omics biomarker identification

2025-10-03

Abstract excerpt

Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant muscle disorder characterized by a complex genetic etiology, variable prognosis, and a lack of effective therapies. Previous studies have identified candidate protein and miRNA biomarkers using various profiling techniques, underscoring their potential for monitoring FSHD, assessing prognosis, and evaluating pharmacodynamic responses. However,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fdb3761b-ebc5-5cd2-9657-6b91f332c80a
DOI
10.1101/2025.10.01.679831
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Leveraging AI for facioscapulohumeral muscular dystrophy prediction and omics biomarker identificationDOI 10.1101/2025.10.01.679831
Gene discovery for facioscapulohumeral muscular dystrophy by machine learning techniques.Semantic proximity
Multi-Omics Identifies Circulating miRNA and Protein Biomarkers for Facioscapulohumeral DystrophySemantic proximity
A circulating biomarker of facioscapulohumeral muscular dystrophy clinical severity, valid in skeletal muscle and bloodSemantic proximity
Multi-scale machine learning model predicts muscle and functional disease progression in FSHDSemantic proximity
A machine learning-based clinical tool for diagnosing myopathy using multi-cohort microarray expression profilesSemantic proximity
Assessing Facioscapulohumeral Muscular Dystrophy through Comparative Analysis of Bulk and Single-Cell TranscriptomesSemantic proximity
Identification of novel biomarkers and drug targets for frailty-related skeletal muscle aging: a multi-omics studySemantic proximity
Artificial Intelligence and Neuromuscular Diseases: A Narrative Review of Applications to Diagnosis, Prognosis, and TherapeuticsSemantic proximity
A cross sectional study of two independent cohorts identifies serum biomarkers for facioscapulohumeral muscular dystrophy (FSHD)Semantic proximity
A Targeted Approach for Evaluating DUX4-Regulated Proteins as Potential Serum Biomarkers for Facioscapulohumeral Muscular Dystrophy Using Immunoassay ProteomicsSemantic proximity
Multiplex Screen of Serum Biomarkers in Facioscapulohumeral Muscular DystrophySemantic proximity
The China facioscapulohumeral muscular dystrophy type 1 (FSHD1) registry: rationale for and description of a nationwide, observational cohort studySemantic proximity
Select a neighboring publication to make it the new centre.